Quick Navigation

Print
 

The European Patent Convention

 
 
Table of Contents - The European Patent Convention
Implementing Regulations to the Convention on the Grant of European Patents
Part II Implementing Regulations to Part II of the Convention
Chapter V Biotechnological inventions
Rule 30 Requirements of European patent applications relating to nucleotide and amino acid sequences
Rule 30[23]
Requirements of European patent applications relating to nucleotide and amino acid sequences 
Art. 56, 57, 80
R. 42
(1)
If nucleotide or amino acid sequences are disclosed in the European patent application, the description shall contain a sequence listing conforming to the rules laid down by the President of the European Patent Office for the standardised representation of nucleotide and amino acid sequences. 
(2)
A sequence listing filed after the date of filing shall not form part of the description. 
(3)
Where the applicant has not filed a sequence listing complying with the require-ments under paragraph 1 at the date of filing, the European Patent Office shall invite the applicant to furnish such a sequence listing and pay the late furnishing fee. If the applicant does not furnish the required sequence listing and pay the required late furnishing fee within a period of two months after such an invitation, the application shall be refused.
 
[23] See decision of the President of the EPO, OJ EPO 2011, 372, and the notice from the EPO, OJ EPO 2011, 376.
References
Art. 56, 57, 80
R. 42
 
Cross-reference list
EPC EPC 1973
R. 30R. 27a(1), (4)